BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9249895)

  • 1. Analysis of charge distribution of lambda- and kappa-IgA in IgA nephropathy by focused antigen capture immunoassay.
    Suen KK; Lewis WH; Lai KN
    Scand J Urol Nephrol; 1997 Jun; 31(3):289-93. PubMed ID: 9249895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charge distribution of IgA-lambda in IgA nephropathy.
    Lai KN; Chui SH; Lewis WH; Poon AS; Lam CW
    Nephron; 1994; 66(1):38-44. PubMed ID: 8107951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy.
    Chen N; Nusbaum P; Halbwachs-Mecarelli L; Lesavre P
    Nephrol Dial Transplant; 1991; 6(11):846-50. PubMed ID: 1775249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy.
    Lai KN; To WY; Li PK; Leung JC
    Kidney Int; 1996 Mar; 49(3):839-45. PubMed ID: 8648928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light-chain ratio of serum IgA1 in IgA nephropathy.
    Chui SH; Lam CW; Lewis WH; Lai KN
    J Clin Immunol; 1991 Jul; 11(4):219-23. PubMed ID: 1918269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
    Zachova K; Jemelkova J; Kosztyu P; Ohyama Y; Takahashi K; Zadrazil J; Orsag J; Matousovic K; Galuszkova D; Petejova N; Mestecky J; Raska M
    J Am Soc Nephrol; 2022 May; 33(5):908-917. PubMed ID: 35115327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant synthesis of IgA with lambda light chain in IgA nephropathy.
    Lai KN; Chui SH; Lai FM; Lam CW
    Kidney Int; 1988 Feb; 33(2):584-9. PubMed ID: 3129610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.
    Leung JC; Tang SC; Chan DT; Lui SL; Lai KN
    J Clin Lab Anal; 2002; 16(1):11-9. PubMed ID: 11835525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light chain composition of IgA in IgA nephropathy.
    Lai KN; Lai FM; Lo ST; Lam CW
    Am J Kidney Dis; 1988 May; 11(5):425-9. PubMed ID: 3130751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of charge of kappa and lambda chain-containing serum immunoglobulin A by immunoblotting and densitometry.
    Chui SH; Lewis WH; Lam CW; Lai KN
    Clin Biochem; 1993 Apr; 26(2):97-100. PubMed ID: 8485863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunochemical characterization of the light chains in the mesangial IgA deposits in IgA nephropathy.
    Lai KN; Chan KW; Mac-Moune F; Ho CP; Yan KW; Lam CW; Vallance-Owen J
    Am J Clin Pathol; 1986 May; 85(5):548-51. PubMed ID: 3085470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunofluorescence characterization of light chains in human nephropathies.
    Orfila C; Rakotoarivony J; Manuel Y; Suc JM
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(6):591-4. PubMed ID: 3129870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy.
    Leung JC; Tang SC; Lam MF; Chan TM; Lai KN
    Kidney Int; 2001 Jan; 59(1):277-85. PubMed ID: 11135081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of kappa and lambda light chains in serum immunoglobulins G, A and M.
    Haraldsson A; Kock-Jansen MJ; Jaminon M; van Eck-Arts PB; de Boo T; Weemaes CM; Bakkeren JA
    Ann Clin Biochem; 1991 Sep; 28 ( Pt 5)():461-6. PubMed ID: 1958048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compositional similarity between immunoglobulins binding to asialo-, agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy.
    Takatani T; Iwase H; Itoh A; Nakamura I; Hayashi M; Sakamoto H; Kamata K; Kobayashi Y; Hiki Y; Okamoto M; Higashihara M
    J Nephrol; 2004; 17(5):679-86. PubMed ID: 15593035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of polymeric lambda-IgA binding to leukocytes in IgA nephropathy.
    Lai KN; Chan LY; Tang SC; Tsang AW; Guo H; Tse KC; Yip T; Leung JC
    J Am Soc Nephrol; 2002 Sep; 13(9):2309-19. PubMed ID: 12191975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light chain ratios of serum immunoglobulins in disease.
    Lam CW; Chui SH; Leung NW; Li EK; Lai KN
    Clin Biochem; 1991 Jun; 24(3):283-7. PubMed ID: 1908361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of monoclonal IgA deposition in patients with IgA nephropathy.
    Nagae H; Tsuchimoto A; Tsuruya K; Kawahara S; Shimomura Y; Noguchi H; Masutani K; Katafuchi R; Kitazono T
    Clin Exp Nephrol; 2017 Apr; 21(2):266-274. PubMed ID: 27170372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.